Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00071097
Status:
COMPLETED
Last Update Posted:
2016-09-20
First Post:
2003-10-10
Brief Title:
TMC114-C202 A Study of Safety Efficacy and Tolerability of TMC114 and Low Dose Ritonavir in HIV-1 Infected Patients
Sponsor:
Tibotec Pharmaceuticals Ireland
Organization:
Tibotec Pharmaceuticals Ireland
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-10
Start Date Type:
None
Primary Completion Date:
2005-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-11
Completion Date Type:
ACTUAL
First Submit Date:
2003-10-10
First Submit QC Date:
October 14 2003
Study First Post Date:
2003-10-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-09-19
Last Update Post Date:
2016-09-20
Last Update Post Date Type:
ESTIMATED